Wow..
So to put it simply, management clearly stated no amount was owed from the DFA if the trial does not meet its endpoint.
Now the trial has failed to meet its end point - management now state it is possible that under the DFA Opthea could become required to pay back.
Clearly a very black and white contradiction here.
Add to My Watchlist
What is My Watchlist?